P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
5.24
-0.01 (-0.19%)
At close: Dec 5, 2025, 4:00 PM EST
5.35
+0.11 (2.10%)
After-hours: Dec 5, 2025, 7:54 PM EST
P3 Health Partners Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for P3 Health Partners stock have an average target of 16.25, with a low estimate of 12.5 and a high estimate of 20. The average target predicts an increase of 210.11% from the current stock price of 5.24.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for P3 Health Partners stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $20 → $13 | Strong Buy | Maintains | $20 → $13 | +138.55% | Nov 17, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +281.68% | Aug 28, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $50 → $20 | Strong Buy | Maintains | $50 → $20 | +281.68% | Apr 21, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $45 → $13 | Hold | Maintains | $45 → $13 | +138.55% | Nov 20, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 1, 2024 |
Financial Forecast
Revenue This Year
1.46B
from 1.50B
Decreased by -3.03%
Revenue Next Year
1.61B
from 1.46B
Increased by 10.45%
EPS This Year
-23.29
from -54.06
EPS Next Year
-11.81
from -23.29
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.5B | 1.7B | |
| Avg | 1.5B | 1.6B | |
| Low | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.4% | 19.7% | |
| Avg | -3.0% | 10.4% | |
| Low | -7.5% | 2.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -20.69 | -0.41 | |
| Avg | -23.29 | -11.81 | |
| Low | -25.44 | -21.33 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.